Company Profile

Proteogenix SA is a biotech company based on two complementary activities :

On the one hand, we offer to all our customers our know-how and skills through cellular and molecular biology, and immunology services (custom monoclonal and polyclonal antibody development, recombinant protein production and purification, gene synthesis…etc) and end products (antibodies, proteins, Elisa kits, TMA…etc).

On the other hand, we research and develop innovative diagnostic and screening products for cancers. Indeed, thanks to our one hybrid screening platform, we identify new interesting targets that we validate through corresponding antibodies and proteins designed especially for it. ELISA assays are designed to characterize target expression on human patient serum samples. 5 targets are currently being developed at different stages of progression. The company’s mission is to offer to the health community new tools for the diagnostic and screening of cancers in order to actively participate in decreasing morbidity related to these ever more frequent pathologies. The marketing of our know-how in molecular and cellular biology and immunology contributes to the financing of R&D work required to meet this goal.